Provalis - The news and views thread

I don't own any PRO, and am not going to (before someone tells me I want them cheap), but MHO:

Loss making, declining businesses don't sell for >1x revenues. I'd say £5m would be a good result and you should brace yourself for less than that once transaction costs come out.

Pro today is at £6.2m all in. I'd say that was 60% Pharma and 40% technology value for In2It and sounds about right until the technology works and market demand proven.

I think they'll be trying to sell both bits (the technology might go to Abbott or suchlike?) - PRO is just too small for the market now.

JJ